Table 1: Demographic and Clinical Characteristics - Obj_1_AF for positivecovidtest
	Total	non-use	current use

1	   70,266 (100.0)	   17,984 (100.0)	   52,282 (100.0)

Grouped age
1	      296 (0.4)	      170 (0.9)	      126 (0.2)
2	    1,371 (2.0)	      613 (3.4)	      758 (1.4)
3	    7,022 (10.0)	    2,361 (13.1)	    4,661 (8.9)
4	   21,886 (31.1)	    6,123 (34.0)	   15,763 (30.1)
5	   28,881 (41.1)	    6,204 (34.5)	   22,677 (43.4)
6	   10,810 (15.4)	    2,513 (14.0)	    8,297 (15.9)

Male
0	   16,198 (23.1)	    5,333 (29.7)	   10,865 (20.8)
1	   54,068 (76.9)	   12,651 (70.3)	   41,417 (79.2)

Grouped BMI
1	      754 (1.1)	      255 (1.4)	      499 (1.0)
2	   16,421 (23.4)	    4,652 (25.9)	   11,769 (22.5)
3	   23,797 (33.9)	    5,933 (33.0)	   17,864 (34.2)
4	   14,356 (20.4)	    3,280 (18.2)	   11,076 (21.2)
5	    6,134 (8.7)	    1,388 (7.7)	    4,746 (9.1)
6	    3,610 (5.1)	      738 (4.1)	    2,872 (5.5)
.	    5,194 (7.4)	    1,738 (9.7)	    3,456 (6.6)

Smoking status
1	   25,846 (36.8)	    6,894 (38.3)	   18,952 (36.2)
2	   38,623 (55.0)	    9,267 (51.5)	   29,356 (56.1)
3	    5,658 (8.1)	    1,774 (9.9)	    3,884 (7.4)
.	      139 (0.2)	       49 (0.3)	       90 (0.2)

Ethnicity
1	   50,585 (72.0)	   12,792 (71.1)	   37,793 (72.3)
2	      150 (0.2)	       48 (0.3)	      102 (0.2)
3	      832 (1.2)	      326 (1.8)	      506 (1.0)
4	      307 (0.4)	      123 (0.7)	      184 (0.4)
5	      305 (0.4)	       90 (0.5)	      215 (0.4)
.	   18,087 (25.7)	    4,605 (25.6)	   13,482 (25.8)

Index of Multiple Deprivation (IMD)
1	   15,047 (21.4)	    3,716 (20.7)	   11,331 (21.7)
2	   14,502 (20.6)	    3,652 (20.3)	   10,850 (20.8)
3	   14,351 (20.4)	    3,663 (20.4)	   10,688 (20.4)
4	   13,441 (19.1)	    3,532 (19.6)	    9,909 (19.0)
5	   12,925 (18.4)	    3,421 (19.0)	    9,504 (18.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	   61,259 (87.2)	   15,357 (85.4)	   45,902 (87.8)
2	    6,027 (8.6)	    1,803 (10.0)	    4,224 (8.1)
3	    2,848 (4.1)	      763 (4.2)	    2,085 (4.0)
4	      132 (0.2)	       61 (0.3)	       71 (0.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
1	   29,255 (41.6)	    7,475 (41.6)	   21,780 (41.7)
Heart Failure
1	    6,995 (10.0)	    1,388 (7.7)	    5,607 (10.7)
Diabetes
1	    9,007 (12.8)	    2,627 (14.6)	    6,380 (12.2)
COPD
1	    6,714 (9.6)	    1,519 (8.4)	    5,195 (9.9)
Other Respiratory Diseases
1	    2,838 (4.0)	      734 (4.1)	    2,104 (4.0)
Cancer
1	   10,672 (15.2)	    2,760 (15.3)	    7,912 (15.1)
Immunosuppressed (combination algorithm)
1	      694 (1.0)	      257 (1.4)	      437 (0.8)
Chronic kidney disease
1	   10,430 (14.8)	    2,024 (11.3)	    8,406 (16.1)
Flu vaccine
1	   50,534 (71.9)	   11,026 (61.3)	   39,508 (75.6)
Recent Oestrogen
1	      597 (0.8)	      246 (1.4)	      351 (0.7)
Recent antiplatelet
1	    6,224 (8.9)	    3,941 (21.9)	    2,283 (4.4)
Myocardial infarction
1	    2,359 (3.4)	      753 (4.2)	    1,606 (3.1)
Peripheral arterial disease
1	      633 (0.9)	      209 (1.2)	      424 (0.8)
Stroke/Transient ischaemic attack
1	    1,357 (1.9)	      333 (1.9)	    1,024 (2.0)
Venous thromboembolism
1	      865 (1.2)	      318 (1.8)	      547 (1.0)


GP consultation count
Median (IQR)	9 (5-15)	7 (3-12)	10 (5-16)
Min, Max	0, 201	0, 201	0, 198
Age (years)
Median (IQR)	71 (65-75)	69 (63-74)	71 (66-75)
Min, Max	18, 106	21, 106	18, 101
A&E attendance count
Median (IQR)	0 (0-1)	0 (0-0)	0 (0-1)
Min, Max	0, 54	0, 39	0, 54
